Persimmon leaf extract inhibits the ATM activity during DNA damage response induced by doxorubicin in A549 lung adenocarcinoma cells

Bioscience, Biotechnology and Biochemistry

Volumn 75, Issue 4, 2011, Pages 650-655

  Kawakami, Kayoko ^a   Nishida, Hiroshi ^a   Tatewaki, Naoto ^a   Nakajima, Yuki ^a   Konishi, Tetsuya ^a   Hirayama, Masao ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Ataxia telangiectasia mutated; Checkpoint; DNA damage; Galloylated flavonol glycoside; Persimmon leaf

Indexed keywords

ATAXIA-TELANGIECTASIA MUTATED; CHECKPOINT; DNA DAMAGE; GALLOYLATED FLAVONOL GLYCOSIDE; PERSIMMON LEAF;

AUTOMATIC TELLER MACHINES; CHEMOTHERAPY; DISEASES; INTERNET PROTOCOLS; PHOSPHORYLATION; SUGARS;

DNA;

ANTINEOPLASTIC AGENT; ATM PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DOXORUBICIN; FLAVONOL DERIVATIVE; PLANT EXTRACT; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; ARTICLE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL SURVIVAL; CHEMISTRY; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LUNG TUMOR; METABOLISM; PATHOLOGY; PERSIMMON; PHOSPHORYLATION; PLANT LEAF; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DIOSPYROS; DNA DAMAGE; DNA-BINDING PROTEINS; DOXORUBICIN; FLAVONOLS; G2 PHASE; HUMANS; LUNG NEOPLASMS; PHOSPHORYLATION; PLANT EXTRACTS; PLANT LEAVES; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA; DIOSPYROS;

EID: 79955838535     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100738     Document Type: Article

References (35)

1. Shiloh Y, Curr. Opin. Genet. Dev., 11, 71-77 (2001).
2. Abraham RT, Genes Dev., 15, 2177-2196 (2001).
3. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ, Science, 316, 1160-1166 (2007).
4. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, and Friend S, Cancer Res., 55, 1643-1648 (1995).
5. Nishida H, Tatewaki N, Nakajima Y, Magara T, Ko KM, Hamamori Y, and Konishi T, Nucleic Acids Res., 37, 5678-5689 (2009).
6. Sakanaka S, Tachibana Y, and Okada Y, Food Chem., 89, 569-575 (2005).
7. Bei W, Peng W, Ma Y, and Xu A, Life Sci., 76, 1975-1988 (2005).
8. Khanal P, Oh WK, Thuong PT, Cho SD, and Choi HS, Planta Med., 76, 689-693 (2010).
9. Chen G, Xue J, Xu SX, and Zhang RQ, J. Asian Nat. Prod. Res., 9, 347-353 (2007).
10. Funayama S and Hikino H, Chem. Pharm. Bull. (Tokyo), 27, 2865-2868 (1979).
11. Kameda K, Takaku T, Okuda H, Kimura Y, Okuda T, Hatano T, Agata I, and Arichi S, J. Nat. Prod., 50, 680-683 (1987).
12. Matsumoto M, Kotani M, Fujita A, Higa S, Kishimoto T, Suemura M, and Tanaka T, Br. J. Dermatol., 146, 221-227 (2002).
13. Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, Suemura M, Kishimoto T, and Tanaka T, J. Allergy Clin. Immunol., 106, 159-166 (2000).
14. Kawakami K, Aketa S, Nakanami M, Iizuka S, and Hirayama M, Biosci. Biotechnol. Biochem., 74, 1380-1385 (2010).
15. Kawakami K, Shibukura Y, Kanno T, Furuki T, Aketa S, and Hirayama M, Phytochem. Anal., in press.
16. Masuda T, Iritani K, Yonemori S, Oyama Y, and Takeda Y, Biosci. Biotechnol. Biochem., 65, 1302-1309 (2001).
17. Yamauchi R, Sasaki K, and Yoshida K, Toxicol. In Vitro, 23, 834-839 (2009).
18. Ravindranath MH, Ramasamy V, Moon S, Ruiz C, and Muthugounder S, Evid. Based Complement. Alternat. Med., 6, 523-530 (2009).
19. Kawai Y, Matsui Y, Kondo H, Morinaga H, Uchida K, Miyoshi N, Nakamura Y, and Osawa T, Chem. Res. Toxicol., 21, 1407-1414 (2008).
20. Hatano T, Yasuhara T, Yoshihara R, Ikegami Y, Matsuda M, Yazaki K, Agata I, Nishibe S, Noro T, Yoshizaki M, and Okuda T, Planta Med., 57, 83-84 (1991).
21. Ahn MJ, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, Lee BB, Shin CG, Huh H, and Kim J, Planta Med., 68, 457-459 (2002).
22. Jo HY, Kim Y, Nam SY, Lee BJ, Kim YB, Yun YW, and Ahn B, J. Vet. Sci., 9, 267-272 (2008).
23. Collis SJ, Swartz MJ, Nelson WG, and DeWeese TL, Cancer Res., 63, 1550-1554 (2003).
24. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, and Abraham RT, Cancer Res., 59, 4375-4382 (1999).
25. Kurz EU, Douglas P, and Lees-Miller SP, J. Biol. Chem., 279, 53272-53281 (2004).
26. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, and Ziv Y, Science, 281, 1674-1677 (1998).
27. Zhou BB and Bartek J, Nat. Rev. Cancer, 4, 216-225 (2004).
28. Liu L, Choi JH, Yim H, Choi JS, Park BD, Cho SJ, and Lee SK, Int. J. Biochem. Cell Biol., 41, 1410-1420 (2009).
29. Jardim MJ, Wang Q, Furumai R, Wakeman T, Goodman BK, and Wang XF, Mol. Biol. Cell, 20, 3801-3809 (2009).
30. Ward IM and Chen J, J. Biol. Chem., 276, 47759-47762 (2001).
31. Levine AJ, Cell, 88, 323-331 (1997).
32. Leach SD, Scatena CD, Keefer CJ, Goodman HA, Song SY, Yang L, and Pietenpol JA, Cancer Res., 58, 3231-3236 (1998).
33. Kawabe T, Mol. Cancer Ther., 3, 513-519 (2004).
34. Liu DP, Song H, and Xu Y, Oncogene, 29, 949-956 (2010).
35. Wang Y, Li J, Booher RN, Kraker A, Lawrence T, Leopold WR, and Sun Y, Cancer Res., 61, 8211-8217 (2001).